📣The first volunteer has received a dose of @ox.ac.uk's Lassa fever vaccine candidate in a Phase I trial funded by CEPI. The deadly haemmorhagic fever causes annual outbreaks across West Africa, however no vaccine is currently available for use (1/2).

Last month, CEPI had the pleasure of welcoming Marjolijn Sonnema, Vice Minister of Health of the Netherlands, to The Aurum Institute in Johannesburg.

CEPI’s November newsletter is out! 🗞️ This edition spotlights recent regulatory “pressure test” simulations in Brasilia and Mombasa, early clinical progress on a Lassa fever vaccine, new partnerships to speed up vaccine manufacturing and release, and lots more. www.linkedin.com/pulse/pressu...

CEPI’s new publication lays out the blueprint for equitable access at the heart of the organisation’s outbreak R&D. Our Pathogen Archetype Frameworks details four pathogen archetypes, which ultimately guide CEPI’s access funding, advocacy, and catalysing efforts. Learn more in the blog ⬇️

Join WAHO, CEPI & partners for a webinar launching the Lassa Fever Research Agenda & open-access Repository—key tools to guide research, inform policy, and support timely, equitable vaccine introduction. 📅 25 Nov | 🕛 12:00 GMT 🔗 Register: bit.ly/4i8pYxT

A new CEPI-funded initiative with LumaCyte and IDT Biologika aims to overcome a major hurdle in vaccine manufacturing: the slow, complex process of potency testing.

The Regionalized Vaccine Manufacturing Collaborative (RVMC) has released its first Status Report - a major step toward building sustainable, regionally-led vaccine manufacturing across Africa, Southeast Asia, and Latin America and the Caribbean.

Sterility testing — ensuring vaccine batches are free from microbial contamination — can take up to a month. With new CEPI funding of up to $199,238, USA-based CBio will develop a rapid sterility testing system based on its cellPhoresis™ technology.

The West African Health Organization(WAHO), with support from CEPI and other partners, have launched the first-ever Lassa Fever Vaccine Policy Research Agenda. Read in full: bit.ly/4nTNVdO

The world remains dangerously underprepared for future pandemics. A new report from the G20 HLIP – co-chaired by CEPI Board Chair, Jane Halton – warns urgent action is needed to close financing gaps and strengthen defences against biological threats. Read the full report ⬇️

CEPI is truly honoured to receive Research!America’s 2026 Advocacy Award for Outstanding Achievement in Public Health. The award recognises a public–private partnership that has made a critical and timely contribution to public health progress ⬇️

What do you know about CEPI's 100 Days Mission? More than eight million people who died during the COVID-19 pandemic might be alive today if the world had achieved the 100 Days Mission to develop safe and effective new vaccines against the novel SARS-SoV-2 virus.

💡West Africa is one step closer to being protected against the deadly Lassa fever disease with IAVI's vaccine candidate, supported by CEPI, showing promise in the first stage of clinical testing. Results from the Phase I trial are published in @nejm.org.

Broadly protective coronavirus vaccines could offer an alternative to the ‘one bug, one drug' approach. We spoke to Dr Michael Osterholm, Director of CIDRAP, about a new CEPI-funded initiative mapping out research into all-in-one coronavirus vaccines ⬇️ cepi.net/big-one-comi...

A busy month in the world of epidemic and pandemic preparedness ⬇️ Explore CEPI's October newsletter to discover how Germany is helping boost global health security, our latest R&D and manufacturing partnerships, and all the other usual features, too.

One of the world’s deadliest viral pathogens, Nipah virus, could soon have a new line of defence against it as CEPI, the University of Oxford and Serum Institute of India collaborate to create the world’s largest investigational ready reserve of a Nipah virus vaccine candidate.

One of the world’s deadliest viral pathogens, Nipah virus, could soon have a new line of defence against it as CEPI, the University of Oxford and Serum Institute of India collaborate to create the world’s largest investigational ready reserve of a Nipah virus vaccine candidate.

New CEPI-funded project will harness innovative microbial testing methods to accelerate vaccine sterility testing from weeks to days. CEPI funding of up to US$197,280 will support Swedish-based Symcel to develop a rapid sterility testing method for vaccines using its calScreener+ platform.

Last month, Health Emergencies Response Canada (HERC) and CEPI co-chaired a roundtable in Ottawa with organisations funding and delivering R&D for diagnostics, vaccines and therapeutics for epidemic and pandemic threats.

Following the recent framework agreement with Fondation Mérieux, CEPI is also partnering with the @ukhsa.bsky.social to support biosecurity capacity strengthening with national public health institutions and universities involved in epidemic preparedness and infectious disease research across DRC.

New CEPI-funded project will partner with Austria’s GENSPEED Biotech to repurpose its GENSPEED R2 device to create a fast, fully automated quality control test for detecting residual HEK293 host cell proteins, a critical step in ensuring vaccine safety and consistency.

CEPI and Serum Institute of India Pvt. Ltd. (SII)—the world’s largest vaccine manufacturer—are collaborating to boost pandemic response preparedness using a baculovirus vaccine platform to target H5N1 bird flu as a prototype for a potential Disease X.

A packed room and lively discussion marked CEPI’s @worldhealthsummit.bsky.social panel “Preparing for Future Pandemics – From Fragmentation to Cohesion.” ➡️ Watch in full here: bit.ly/42uCAsS Or see the toplines and what else CEPI got up to at this year's WHS 👇

CEPI and Serum Institute of India Pvt. Ltd. (SII)—the world’s largest vaccine manufacturer—are collaborating to boost pandemic response preparedness using a baculovirus vaccine platform to target H5N1 bird flu as a prototype for a potential Disease X.

"Pandemics are not hypothetical risks. They are existential threats and defending against them is both a strategic and moral imperative.” That was the clear message from Dorothee Bär, German Federal Minister of Research, Technology and Space & CEPI CEO @drrhatchett.bsky.social below ⬇️

📢 Germany reaffirms its global health leadership with a EUR 100M pledge to CEPI. This continued support helps power CEPI’s mission to take many of the world’s most dangerous epidemic and pandemic threats off the table for the benefit of all. cepi.net/bmftr-boosts...

📢 Die Bundesrepublik Deutschland hat ihre weltweite Vorreiterrolle im Gesundheitsbereich mit einer erneuten Zusage in Höhe von 100 Millionen Euro für CEPI bekräftigt.

Will you be in Berlin for the @worldhealthsummit.bsky.social? CEPI is organising a thought-provoking panel entitled “Preparing for Future Pandemics – From Fragmentation to Cohesion” on 12 October 2025, 16:00–17:30 CEST ⬇️ bit.ly/3WvE9TI

New topline data from a clinical trial co-funded by CEPI assessing Bavarian Nordic's Mpox vaccine in children found that the vaccine was safe and generated an immune response not-inferior to when vaccinating adults. Our new blog looks at the breadth of our work tackling the deadly Mpox virus⤵️

New $1 million CEPI funding to AVAREF will invite regulators and ethicists to AVAREF joint review processes and simulation exercises to optimise the speed at which clinical trials of infectious disease vaccines are approved in Africa⤵️ cepi.net/cepi-partner...

Could a single vaccine protect people against Zaire ebolavirus, Marburg and Sudan ebolavirus – some of the deadliest viruses known to humankind? A CEPI-funded project is set to find out…

Could a single vaccine protect people against Zaire ebolavirus, Marburg and Sudan ebolavirus – some of the deadliest viruses known to humankind? A CEPI-funded project is set to find out…

📅 Don't miss @cepi.net #WHS2025 event, Preparing for Future Pandemics: From Fragmentation to Cohesion on 12 Oct! Not going in person? Tune into the livestream 📺 www.worldhealthsummit.org/sessions/7ac...

How can #AI accelerate vaccine development and strengthen pandemic preparedness? This was the question explored last week on the sidelines of #UNGA80 as CEPI and @foreignpolicy.com brought together global health leaders, researchers, policymakers, and technologists.

New research in Nature Communications reveals that all-in-one coronavirus vaccines could save millions of lives, dramatically reduce economic disruption and limit the need for lockdowns in future pandemics ⬇️

Future pandemics demand future-ready tools. That’s why CEPI is planning to develop a revolutionary new artificial intelligence platform called the Pandemic Preparedness Engine – a kind of ChatGPT dedicated to accelerating pandemic vaccine development ➡️ bit.ly/3WfakGS

What's been happening in the world of epidemic and pandemic preparedness this month? Find out in CEPI's September newsletter 🗞️

Future pandemics demand future-ready tools. That’s why CEPI is planning to develop a revolutionary new artificial intelligence platform called the Pandemic Preparedness Engine – a kind of ChatGPT dedicated to accelerating pandemic vaccine development ➡️ bit.ly/3WfakGS

CEPI is partnering with UKHSA & Fondation Mérieux through two new framework agreements aimed at strengthening biosecurity capacities in the DRC, supporting CEPI’s existing R&D partners in the region. 📸 CEPI's Andrew Hebbeler signing the new partnership with Fondation Mérieux on sidelines of UNGA.

From vaccine breakthroughs and our role in COVAX, to driving forward the 100 Days Mission and lots more, explore CEPI's progress and results, so far, below ⬇️ cepi.net/our-impact/p...

📺💡A new BBC Horizon documentary, ‘Disease X: Hunting the next pandemic’ delves into the potential deadly threat of a future unknown disease that could spread globally – and the possible culprit viral families it could come from, such as a virus related to the deadly Nipah or influenza strains (1/3)

What role can regional & global partnerships play in responding to future outbreaks? How can Africa strengthen its vaccine sovereignty? Which breakthroughs will accelerate vaccine access? Speaking with @nigeriahealthwatch.bsky.social, CEPI's Dr Amadou Sall shares his thoughts on these questions ⬇️

If we were to achieve our #100DaysMission, we could stay one step ahead of infectious diseases and outbreaks could be stopped before they ever spiralled into pandemics. More on our website ⬇️

In this Innovation for Impact story, discover how CEPI's funding is helping Africa achieve vaccine sovereignty, driven by expertise from regional partners like Senegal's Institut Pasteur de Dakar 🇸🇳

Congratulations to the inaugural cohort of Biosecurity Game Changers Fellows! Over the last year, 8 fellows worked across the globe partnered with leading organizations to advance global #biosecurity. More via @brownpublichealth.bsky.social ⤵️

The reach of the potentially deadly #RiftValley fever is expanding, yet no vaccines are currently approved for human use. We’re looking to change that ⬇️

📣 Four global health and science experts, widely recognised for their contributions in tackling deadly infectious disease threats, have been appointed to key governance positions at CEPI. ▶️ cepi.net/top-health-a...

Did you know the next pandemic is likely to emerge from one of 25 or so viral families? Learning as much as possible about them now & building a library of knowledge is helping scientists get ahead of this threat. Discover the families in CEPI's The Viral Most Wanted ➡️ cepi.net/viral-most-w...

📣We're providing up to $10.4 million to work with international partners and gather real-world insights into the use of the Lc16m8 vaccine in protecting against mpox in the DRC. The research could help tackle the ongoing mpox outbreak which remains a continental emergency👉 cepi.net/new-mpox-vac...

New @weforum.org article, co-authored by CEPI's Director of Biosecurity, Andrew Hebbeler, explores the latest international initiatives shaping the norms and practices required to embrace AI innovation in the bioeconomy safely, responsibly and equitably. @ibbis-bio.bsky.social Check it out ⬇️